COMP <GO>
HSIC vs LLY // FREE CASH FLOW YIELD
Henry Schein Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: HSIC 4
— LLY 11
▲ FREE CASH FLOW YIELD LEADER: LLY
LAST: $84.88 (-1.80%) • MKT CAP: $9.63B
fcf-yield
1.23%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
fcf-yield
2.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSIC VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSIC | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.10% | 83.64% | -52.54 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.20% | 32.36% | -21.16 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.5x | 36.4x | -26.92 | HSIC | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 1.23% | 2.30% | -1.07 | LLY | /fcf-yield <GO> |
| Operating Margin | 5.00% | 40.21% | -35.21 | LLY | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 31.90% | -28.70 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 45.51% | -41.51 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 9.29 | -6.48 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.77% | -0.27 | HSIC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 77.9 | -30.08 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.51 | +0.38 | HSIC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.4x | 26.3x | -4.85 | HSIC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.63B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSIC REV | LLY REV | HSIC GROSS % | LLY GROSS % | HSIC FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.18B | $65.18B | 31.1% | 83.0% | $118.7M | $16.81B |
| FY 2024 | $12.67B | $45.04B | 31.7% | 81.3% | $277.7M | $8.82B |
| FY 2023 | $12.34B | $34.12B | 44.0% | 79.3% | -$55.3M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSIC // BETA 0.89
LLY // BETA 0.51